{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:48:32Z","timestamp":1783003712978,"version":"3.54.5"},"reference-count":46,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T00:00:00Z","timestamp":1645920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Ovarian cancer is the fourth-most-common cause of death among all malignant cancers in women in Poland. This study aimed to compare the functioning of the urinary system and quality of life in women in the 12-month period following the completion of surgery or adjuvant treatment for ovarian cancer, with patients who underwent a hysterectomy for non-oncological reasons (control group). The study group consisted of 50 patients diagnosed with stage I\u2013III ovarian cancer. Among 38 patients with type II ovarian cancer (group A), surgery followed by first-line chemotherapy was performed. Within this group of patients, 20 had stage I ovarian cancer, while 18 had stage II ovarian cancer. The study was performed at least 6 months after the final chemotherapy cycle, with no clinical, marker or radiological recurrence determined. On the other hand, in 12 patients with stage I type I ovarian cancer, oncological treatment consisted of only surgery, without the need for adjuvant chemotherapy, due to the low stage of the lesions (group B). In turn, the control group consisted of 50 women who underwent uterine removal for non-oncological reasons (group C). The assessment of quality of life was conducted using the questionnaires: Satisfaction with Life Scale (SWLS); Incontinence Impact Questionnaire, short form (IIQ-7); Urogenital Distress Inventory (UDI-6); and the Sexual Satisfaction Scale for 3, 6, 9, and 12 months after the conclusion of oncological treatment. During the follow-up, a significant reduction in the quality of everyday life and sexual life was noted among patients with ovarian cancer, more pronounced in group B, compared to the control group (p &lt; 0.05). The risk of urinary incontinence is independent of the treatment regimen chosen for ovarian cancer. It is necessary to consider comprehensive psychological care and sexual therapy in patients with ovarian cancer and their families.<\/jats:p>","DOI":"10.3390\/jcm11051300","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T20:47:17Z","timestamp":1645994837000},"page":"1300","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Impact of Surgical Treatment with Adjuvant Chemotherapy for Ovarian Cancer on Disorders in the Urinary System and Quality of Life in Women"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8395-279X","authenticated-orcid":false,"given":"Marcin","family":"Op\u0142awski","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialized Hospital, 31-826 Krak\u00f3w, Poland"},{"name":"Department of Gynecology and Obstetrics, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski University in Cracow, 30-705 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1633-7145","authenticated-orcid":false,"given":"Beniamin Oskar","family":"Grabarek","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialized Hospital, 31-826 Krak\u00f3w, Poland"},{"name":"Department of Histology, Cytophysiology and Embryology in Zabrze, Faculty of Medicine in Zabrze, University of Technology, Academy of Silesia in Katowice, 41-800 Zabrze, Poland"},{"name":"Department of Gynecology and Obstetrics in Zabrze, Faculty of Medicine in Zabrze, University of Technology, Academy of Silesia in Katowice, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"\u015arednicka","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialized Hospital, 31-826 Krak\u00f3w, Poland"},{"name":"Department of Gynecology and Obstetrics, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski University in Cracow, 30-705 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Czarniecka","sequence":"additional","affiliation":[{"name":"Department of Histology, Cytophysiology and Embryology in Zabrze, Faculty of Medicine in Zabrze, University of Technology, Academy of Silesia in Katowice, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Panfil","sequence":"additional","affiliation":[{"name":"Department of Histology, Cytophysiology and Embryology in Zabrze, Faculty of Medicine in Zabrze, University of Technology, Academy of Silesia in Katowice, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Kojs","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialized Hospital, 31-826 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2691-5829","authenticated-orcid":false,"given":"Dariusz","family":"Boro\u0144","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialized Hospital, 31-826 Krak\u00f3w, Poland"},{"name":"Department of Histology, Cytophysiology and Embryology in Zabrze, Faculty of Medicine in Zabrze, University of Technology, Academy of Silesia in Katowice, 41-800 Zabrze, Poland"},{"name":"Department of Gynecology and Obstetrics in Zabrze, Faculty of Medicine in Zabrze, University of Technology, Academy of Silesia in Katowice, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"viii61","DOI":"10.1093\/annonc\/mdx443","article-title":"Real-world evidence in the treatment of ovarian cancer","volume":"28","author":"Eisenhauer","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1039\/C8MO00128F","article-title":"Clinical significance of the immune microenvironment in ovarian cancer patients","volume":"14","author":"Yang","year":"2018","journal-title":"Mol. Omics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41416-019-0718-9","article-title":"Improved early detection of ovarian cancer using longitudinal multimarker models","volume":"122","author":"Whitwell","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13048-019-0503-7","article-title":"Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review","volume":"12","author":"Dochez","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.23736\/S0026-4806.19.06078-6","article-title":"Primary debulking surgery vs. interval debulking surgery for advanced ovarian cancer: Review of the literature and meta-analysis","volume":"110","author":"Chiofalo","year":"2019","journal-title":"Minerva Medica"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"577869","DOI":"10.3389\/fimmu.2020.577869","article-title":"Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/14737140.2018.1458614","article-title":"The role of neoadjuvant chemotherapy in ovarian cancer","volume":"18","author":"Elies","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.hoc.2018.07.010","article-title":"Diagnosis and Treatment of Ovarian Cancer","volume":"32","author":"Orr","year":"2018","journal-title":"Hematol. Clin. North Am."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"12015","DOI":"10.1038\/s41598-017-11821-w","article-title":"Complications following vaginal mesh procedures for stress urinary incontinence: An 8 year study of 92,246 women","volume":"7","author":"Keltie","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejon.2017.07.007","article-title":"Symptom clustering and quality of life in patients with ovarian cancer undergoing chemotherapy","volume":"30","author":"Nho","year":"2017","journal-title":"Eur. J. Oncol. Nurs."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cortex.2020.04.015","article-title":"Tumor grade-related language and control network reorganization in patients with left cerebral glioma","volume":"129","author":"Yuan","year":"2020","journal-title":"Cortex"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11136-020-02648-6","article-title":"A non-compensatory analysis of quality of life in breast cancer survivors using multivariate hidden Markov modeling","volume":"30","author":"Ip","year":"2021","journal-title":"Qual. Life Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Op\u0142awski, M., Smoczy\u0144ska, M., Grabarek, B., and Boro\u0144, D. (2021). Assessment of Dysfunction in the Urinary System as Well as Comfort in the Life of Women during and after Combination Therapy Due to Ovarian and Endometrial Cancer Based on the SWL, II-Q7 and UDI-6 Scales. J. Clin. Med., 10.","DOI":"10.3390\/jcm10061228"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s11136-017-1552-2","article-title":"Measurement invariance of the Satisfaction with Life Scale: Reviewing three decades of research","volume":"26","author":"Emerson","year":"2017","journal-title":"Qual. Life Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5964\/ejop.v15i2.1640","article-title":"Mediating role of resilience in the relationships between fear of happiness and affect balance, satisfaction with life, and flourishing","volume":"15","author":"Yildirim","year":"2019","journal-title":"Eur. J. Psychol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/ard.2006.065763","article-title":"Functional Assessment of Chronic Illness Therapy-Fatigue Scale is valid in patients with psoriatic arthritis","volume":"66","author":"Chandran","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"ref_18","unstructured":"Brouillard, P., \u0160tulhofer, A., and Bu\u0161ko, V. (2019). The New Sexual Satisfaction Scale and Its Short Form. Handbook of sexuality-related measures, Routledge, Taylor & Francis Group."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: An overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/pon.4063","article-title":"How doctors communicate the initial diagnosis of cancer matters: Cancer disclosure and its relationship with Patients\u2019 hope and trust","volume":"26","author":"Cao","year":"2017","journal-title":"Psycho-Oncology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"22832","DOI":"10.18632\/oncotarget.25126","article-title":"Role of tumor microenvironment in ovarian cancer pathobiology","volume":"9","author":"Ghoneum","year":"2018","journal-title":"Oncotarget"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s11255-018-1970-2","article-title":"Cancer survivorship issues with radiation and hemorrhagic cystitis in gynecological malignancies","volume":"50","author":"Zwaans","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/01443615.2019.1584887","article-title":"Urinary incontinence and quality of life in endometrial cancer patients after robotic-assisted laparoscopic hysterectomy with lymph node dissection","volume":"39","author":"Lipetskaia","year":"2019","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2013","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","article-title":"Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Armstrong","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1038\/s41598-019-38759-5","article-title":"Impact of gynecologic cancer on pelvic floor disorder symptoms and quality of life: An observational study","volume":"9","author":"Neron","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_27","first-page":"459","article-title":"Pelvic floor disorders in women with gynecologic malignancies: A systematic review","volume":"29","author":"Ramaseshan","year":"2017","journal-title":"Int. Urogynecology J."},{"key":"ref_28","first-page":"115","article-title":"Urinary and fecal incontinence in patients with advanced ovarian cancer treated with CRS + HIPEC","volume":"36","year":"2020","journal-title":"Surg. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00192-019-04137-y","article-title":"Urinary incontinence and chronic conditions in the US population age 50 years and older","volume":"31","author":"Daugirdas","year":"2020","journal-title":"Int. Urogynecology J."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Przydacz, M., Chlosta, M., and Chlosta, P. (2021). Population-Level Prevalence, Bother, and Treatment Behavior for Urinary Incontinence in an Eastern European Country: Findings from the LUTS POLAND Study. J. Clin. Med., 10.","DOI":"10.3390\/jcm10112314"},{"key":"ref_31","first-page":"675","article-title":"Patient-Reported Outcome Measures: How and Why They Are Collected","volume":"68","author":"Makhni","year":"2019","journal-title":"Instr Course Lect."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/1756-185X.14069","article-title":"Fatigue in psoriatic arthritis: Is it related to disease activity?","volume":"24","author":"Lai","year":"2021","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.12669\/pjms.37.4.3602","article-title":"Fatigue assessment by FACIT-F scale in Pakistani cohort with Rheumatoid Arthritis (FAF-RA) study","volume":"37","author":"Wagan","year":"2021","journal-title":"Pak. J. Med. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00520-021-06488-z","article-title":"Fear, worry and sadness: An exploratory study of psychological wellbeing in men caring for their partner with ovarian cancer","volume":"30","author":"Levesque","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/01.REO.0000000000000229","article-title":"Functional Benefits of Fitness Boxing for Survivors Diagnosed with Breast or Ovarian Cancer: A Pilot Study","volume":"39","author":"Doherty","year":"2021","journal-title":"Rehabilitation Oncol."},{"key":"ref_36","first-page":"121","article-title":"Prospective validation of patient fatigue questionnaire (FACIT-F) for fatigue assessment in nab-paclitaxel plus gemcitabine therapy","volume":"8","author":"Okada","year":"2017","journal-title":"Mol. Clin. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10198-017-0930-6","article-title":"Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia","volume":"20","author":"Meregaglia","year":"2019","journal-title":"Eur. J. Heal. Econ."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.esxm.2019.07.005","article-title":"Sexual Function, Quality of Life, and Experiences of Women with Ovarian Cancer: A Mixed-Methods Study","volume":"7","author":"Fischer","year":"2019","journal-title":"Sex. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/pon.639","article-title":"Post-treatment sexual adjustment following cervical and endometrial cancer: A qualitative insight","volume":"12","author":"Juraskova","year":"2002","journal-title":"Psycho-Oncology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.esxm.2020.04.005","article-title":"Self-Reported Sexual Function in Sexually Active Male Hodgkin Lymphoma Survivors","volume":"8","author":"Eeltink","year":"2020","journal-title":"Sex. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1200\/JCO.2004.08.150","article-title":"Predictors of Sexual Functioning in Ovarian Cancer Patients","volume":"22","author":"Taylor","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Stafford, L., Russell, H., Knoetze, E., Wilson, V., and Little, R. (2022). Sexual Functioning after Ovarian Cancer: Are Women Receiving the Information and Support They Need?. Support. Care Cancer, 1\u20134.","DOI":"10.1007\/s00520-021-06733-5"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00404-018-4922-2","article-title":"Sexual activity and quality of life in patients after treatment for breast and ovarian cancer","volume":"299","author":"Mayer","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"695","DOI":"10.4236\/jct.2020.1111059","article-title":"Quality of Life in Ovarian-Cancer Patients Receiving Chemotherapy","volume":"11","author":"Akhter","year":"2020","journal-title":"J. Cancer Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"8975","DOI":"10.18632\/aging.202724","article-title":"PARP inhibitors in breast and ovarian cancer with BRCA mutations: A meta-analysis of survival","volume":"13","author":"Shao","year":"2021","journal-title":"Aging"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer","volume":"381","author":"Pautier","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/5\/1300\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:28:34Z","timestamp":1760135314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/5\/1300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,27]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["jcm11051300"],"URL":"https:\/\/doi.org\/10.3390\/jcm11051300","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,27]]}}}